Nasdaq · CIK 0000772406
CRUS CIRRUS LOGIC, INC.
Insider trading from SEC Form 4. Last filing 20 d ago. Close $106.87 on Oct 9, 2026, 0% from the 52-week low and -40% from the high.
In brief
CIRRUS LOGIC, INC. (CRUS) has 98 SEC Form 4 filings on file from 14 insiders, the latest filed on Sep 23, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 3 open-market sells worth $438k, net -$438k.
40 open-market trades have been scored at CRUS. The newest: Jeffrey W Baumgartner (EVP, R&D) sold $139k of stock on Sep 21, 2026, filed Sep 23, 2026, scored 6 (weak), under a 10b5-1 plan. The largest of the 40 shown: John Forsyth (CEO) sold $2.9M on Feb 4, 2026, scored 40 (moderate), under a 10b5-1 plan. 2 insiders sold within 14 days of each other around Jul 1, 2026.
25 Form 144 notices of planned sales are on file, the latest filed Sep 21, 2026.
Last 90 days
Net insider value
-$438k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
3
$438k by 1 insider
Insiders on file
14
with a Form 4 at this company
Price and insider trades, last year
CRUSOct 9, 2026 · close 106.87
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CIRRUS LOGIC, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 6Weak | Jeffrey W Baumgartner EVP, R&D sell | $139k 1,166 shares | -8% | - | |
| 6Weak | Jeffrey W Baumgartner EVP, R&D sell | $137k 1,166 shares | -8% | +4% from low-35% from high | |
| 6Weak | Jeffrey W Baumgartner EVP, R&D sell | $162k 1,166 shares | -7% | +41% from low-24% from high | |
| 0Weak | Jeffrey W Baumgartner EVP, R&D sell | $213k 1,458 shares | -8% | +51% from low-18% from high | |
| 22Weak | Andrew Brannan EVP, Worldwide Sales sell | $935k 6,464 shares | -47% | +50% from low-18% from high | |
| 15Weak | Jeffrey W Baumgartner EVP, R&D sell | $197k 1,170 shares | -7% | +70% from low-8% from high | |
| 20Weak | Jeffrey W Baumgartner EVP, R&D sell | $658k 3,907 shares | -18% | +75% from low-4% from high | |
| 8Weak | Scott Thomas EVP, General Counsel sell | $234k 1,300 shares | -4% | +84% from low0% from high | |
| 30Weak | Jeffrey W Baumgartner EVP, R&D sell | $1.9M 11,171 shares | -39% | +75% from low-5% from high | |
| 29Weak | Andrew Brannan EVP, Worldwide Sales sell | $289k 1,645 shares | -19% | +75% from low-5% from high | |
| 40Moderate | Justin E Dougherty EVP, Global Operations sell | $333k 2,000 shares | -31% | +71% from low-4% from high | |
| 41Moderate | Alexander M Davern director sell | $159k 1,000 shares | -5% | +71% from low-5% from high | |
| 43Moderate | John Forsyth CEO sell | $852k 5,000 shares | -7% | +77% from low-1% from high | |
| 10Weak | Scott Thomas EVP, General Counsel sell | $1.6M 9,942 shares | -25% | +88% from low0% from high | |
| 41Moderate | Alexander M Davern director sell | $140k 1,000 shares | -4% | +84% from low-3% from high | |
| 12Weak | Scott Thomas EVP, General Counsel sell | $459k 3,239 shares | -10% | +87% from low0% from high | |
| 57Moderate | Justin E Dougherty EVP, Global Operations sell | $429k 3,000 shares | -34% | +82% from low-1% from high | |
| 28Weak | Carl Jackson Alberty EVP, MSP sell | $518k 3,648 shares | -9% | +80% from low-2% from high | |
| 40Moderate | John Forsyth CEO sell | $2.9M 21,806 shares | -30% | +74% from low-0% from high | |
| 33Weak | Andrew Brannan EVP, Worldwide Sales sell | $1.1M 8,913 shares | -120% | +54% from low-12% from high | |
| 13Weak | Carl Jackson Alberty EVP, MSP sell | $117k 1,000 shares | -3% | +53% from low-12% from high | |
| 0Weak | Scott Thomas EVP, General Counsel sell | $96k 734 shares | -3% | +69% from low0% from high | |
| 30Weak | Jeffrey W Baumgartner EVP, R&D sell | $1.1M 9,162 shares | -43% | +54% from low-5% from high | |
| 30Weak | Scott Thomas EVP, General Counsel sell | $1.3M 11,089 shares | -30% | +59% from low-2% from high | |
| 33Weak | Denise Grode EVP, CHRO sell | $257k 2,202 shares | -28% | +51% from low-7% from high | |
| 23Weak | Jeffrey W Baumgartner EVP, R&D sell | $1.1M 10,000 shares | -42% | +46% from low-17% from high | |
| 21Weak | Denise Grode EVP, CHRO sell | $253k 2,208 shares | -22% | +47% from low-16% from high | |
| 39Weak | Justin E Dougherty EVP, Global Operations sell | $167k 1,542 shares | -24% | +40% from low-20% from high | |
| 15Weak | Carl Jackson Alberty EVP, MSP sell | $201k 2,000 shares | -5% | +34% from low-24% from high | |
| 22Weak | Carl Jackson Alberty EVP, MSP sell | $200k 2,000 shares | -5% | +29% from low-27% from high | |
| 30Weak | Jeffrey W Baumgartner EVP, R&D sell | $1.0M 10,000 shares | -42% | +29% from low-27% from high | |
| 40Moderate | Alexander M Davern director sell | $106k 1,000 shares | -5% | +35% from low-24% from high | |
| 49Moderate | Justin E Dougherty EVP, Global Operations sell | $384k 3,838 shares | -38% | +30% from low-26% from high | |
| 0Weak | Scott Thomas EVP, General Counsel sell | $311k 3,000 shares | -10% | - | |
| 12Weak | Jeffrey W Baumgartner EVP, R&D sell | $205k 2,051 shares | -20% | - | |
| 9Weak | Jeffrey W Baumgartner VP, R&D sell | $560k 5,542 shares | -35% | - | |
| 47Moderate | Justin E Dougherty SVP, Global Operations sell | $300k 3,280 shares | -35% | +39% from low-16% from high | |
| 17Weak | Scott Thomas Sr VP, General Counsel sell | $456k 5,043 shares | -20% | +37% from low-17% from high | |
| 35Weak | Andrew Brannan VP, Worldwide Sales sell | $627k 6,750 shares | -103% | +36% from low-18% from high | |
| 33Weak | Venkatesh Nathamuni Chief Financial Officer sell | $140k 1,500 shares | -58% | +36% from low-18% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 21, 2026 | JEFFREY BAUMGARTNER Officer | 3,498 0.01% of outstanding | $416k | Sep 21, 2026 | $709k |
| Jun 3, 2026 | GREGORY SCOTT THOMAS Officer | 1,300 0.00% of outstanding | $222k | Jun 3, 2026 | $1.6M |
| May 29, 2026 | JEFFREY BAUMGARTNER Officer | 20,038 0.04% of outstanding | $3.5M | May 29, 2026 | none |
| May 29, 2026 | ANDREW BRANNAN Officer | 8,109 0.02% of outstanding | $1.4M | May 29, 2026 | none |
| May 21, 2026 | JUSTIN DOUGHERTY Officer | 2,000 0.00% of outstanding | $333k | May 21, 2026 | none |
| May 20, 2026 | ALEXANDER M DAVERN Director | 1,000 0.00% of outstanding | $159k | May 20, 2026 | $280k |
| May 8, 2026 | John Matthew Forsyth Director, Officer | 5,000 0.01% of outstanding | $858k | May 8, 2026 | none |
| Apr 9, 2026 | GREGORY SCOTT THOMAS Officer | 9,942 0.02% of outstanding | $1.5M | Apr 9, 2026 | $459k |
| Feb 20, 2026 | ALEXANDER M DAVERN Director | 1,000 0.00% of outstanding | $140k | Feb 20, 2026 | none |
| Feb 13, 2026 | GREGORY S THOMAS Officer | 3,239 0.01% of outstanding | $460k | Feb 13, 2026 | none |
| Feb 11, 2026 | JUSTIN DOUGHERTY Officer | 3,000 0.01% of outstanding | $430k | Feb 11, 2026 | none |
| Feb 9, 2026 | CARL J ALBERTY Officer | 3,648 0.01% of outstanding | $521k | Feb 9, 2026 | none |
| Feb 4, 2026 | JOHN M FORSYTH Director, Officer | 21,806 0.04% of outstanding | $2.7M | Feb 4, 2026 | none |
| Nov 14, 2025 | ANDREW BRANNAN Officer | 8,913 0.02% of outstanding | $1.1M | Nov 14, 2025 | none |
| Nov 7, 2025 | CARL J ALBERTY Officer | 1,000 0.00% of outstanding | $119k | Nov 7, 2025 | $201k |
| Oct 20, 2025 | GREGORY S THOMAS Officer | 734 0.00% of outstanding | $96k | Oct 20, 2025 | $1.3M |
| Sep 18, 2025 | GREGORY S THOMAS Officer | 11,089 0.02% of outstanding | $1.3M | Sep 18, 2025 | none |
| Sep 17, 2025 | JEFFREY W BAUMGARTNER Officer | 9,162 0.02% of outstanding | $1.1M | Sep 17, 2025 | $1.1M |
| Sep 2, 2025 | JEFFREY W BAUMGARTNER Officer | 10,000 0.02% of outstanding | $1.1M | Sep 2, 2025 | $1.0M |
| Aug 29, 2025 | Denise Grode Officer | 4,410 0.01% of outstanding | $509k | Aug 29, 2025 | none |
| Aug 12, 2025 | JUSTIN DOUGHERTY Officer | 1,542 0.00% of outstanding | $167k | Aug 12, 2025 | none |
| Jun 3, 2025 | CARL J ALBERTY Officer | 4,000 0.01% of outstanding | $391k | Jun 3, 2025 | none |
| Jun 3, 2025 | JEFFREY W BAUMGARTNER Officer | 10,000 0.02% of outstanding | $1.0M | Jun 3, 2025 | none |
| May 21, 2025 | DAVERN ALEXANDER M Director | 1,000 0.00% of outstanding | $106k | May 21, 2025 | none |
| May 9, 2025 | Dougherty Justin E Officer | 3,838 0.01% of outstanding | $384k | May 9, 2025 | none |
Transactions
The newest 50 of 359 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Jeffrey W Baumgartner EVP, R&D | SOpen-market sale Common Stock10b5-1 | -1,166 | $119.00 | $139k | 12,907 | 20 d ago |
| Aug 20, 2026 | Jeffrey W Baumgartner EVP, R&D | SOpen-market sale Common Stock10b5-1 | -1,166 | $117.89 | $137k | 14,073 | Aug 24, 2026 |
| Jul 29, 2026 | Loan T Le Duy director | MOption exercise Common Stock | +1,998 | $0.00 | $0 | 6,197 | Jul 31, 2026 |
| Jul 29, 2026 | Alexander M Davern director | AGrant or award Common Stock | +1,998 | $0.00 | $0 | 22,529 | Jul 31, 2026 |
| Jul 29, 2026 | Muhammad Raghib Hussain director | AGrant or award Common Stock | +1,998 | $0.00 | $0 | 10,579 | Jul 31, 2026 |
| Jul 29, 2026 | David J. Tupman director | AGrant or award Common Stock | +1,998 | $0.00 | $0 | 27,916 | Jul 31, 2026 |
| Jul 29, 2026 | Catherine P Lego director | AGrant or award Common Stock | +1,998 | $0.00 | $0 | 11,708 | Jul 31, 2026 |
| Jul 29, 2026 | William D Mosley director | AGrant or award Common Stock | +1,998 | $0.00 | $0 | 3,622 | Jul 31, 2026 |
| Jul 29, 2026 | William D Mosley director | MOption exercise Restricted Stock Unitsderivative | -1,998 | $0.00 | $0 | 0 | Jul 31, 2026 |
| Jul 29, 2026 | Muhammad Raghib Hussain director | MOption exercise Restricted Stock Unitsderivative | -1,998 | $0.00 | $0 | 0 | Jul 31, 2026 |
| Jul 29, 2026 | Loan T Le Duy director | MOption exercise Restricted Stock Unitsderivative | -1,998 | $0.00 | $0 | 0 | Jul 31, 2026 |
| Jul 29, 2026 | David J. Tupman director | MOption exercise Restricted Stock Unitsderivative | -1,998 | $0.00 | $0 | 0 | Jul 31, 2026 |
| Jul 29, 2026 | Alexander M Davern director | MOption exercise Restricted Stock Unitsderivative | -1,998 | $0.00 | $0 | 0 | Jul 31, 2026 |
| Jul 31, 2026 | Muhammad Raghib Hussain director | AGrant or award Restricted Stock Unitsderivative | +1,623 | $0.00 | $0 | 1,623 | Jul 31, 2026 |
| Jul 31, 2026 | Loan T Le Duy director | AGrant or award Restricted Stock Unitsderivative | +1,623 | $0.00 | $0 | 1,623 | Jul 31, 2026 |
| Jul 31, 2026 | Alexander M Davern director | AGrant or award Restricted Stock Unitsderivative | +1,623 | $0.00 | $0 | 1,623 | Jul 31, 2026 |
| Jul 29, 2026 | Catherine P Lego director | MOption exercise Restricted Stock Unitsderivative | -1,998 | $0.00 | $0 | 0 | Jul 31, 2026 |
| Jul 31, 2026 | William D Mosley director | AGrant or award Restricted Stock Unitsderivative | +1,623 | $0.00 | $0 | 1,623 | Jul 31, 2026 |
| Jul 31, 2026 | David J. Tupman director | AGrant or award Restricted Stock Unitsderivative | +1,623 | $0.00 | $0 | 1,623 | Jul 31, 2026 |
| Jul 31, 2026 | Catherine P Lego director | AGrant or award Restricted Stock Unitsderivative | +1,623 | $0.00 | $0 | 1,623 | Jul 31, 2026 |
| Jul 20, 2026 | Jeffrey W Baumgartner EVP, R&D | SOpen-market sale Common Stock10b5-1 | -1,166 | $138.57 | $162k | 15,239 | Jul 21, 2026 |
| Jul 1, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Common Stock10b5-1 | +1,458 | $68.56 | $100k | 17,863 | Jul 2, 2026 |
| Jul 1, 2026 | Jeffrey W Baumgartner EVP, R&D | SOpen-market sale Common Stock10b5-1 | -1,458 | $145.97 | $213k | 16,405 | Jul 2, 2026 |
| Jul 1, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Incentive Stock Option (right to buy)derivative10b5-1 | -1,458 | $0.00 | $0 | 0 | Jul 2, 2026 |
| Jun 29, 2026 | Andrew Brannan EVP, Worldwide Sales | MOption exercise Common Stock10b5-1 | +6,464 | $88.00 | $569k | 13,667 | Jun 30, 2026 |
| Jun 29, 2026 | Andrew Brannan EVP, Worldwide Sales | SOpen-market sale Common Stock10b5-1 | -6,464 | $144.71 | $935k | 7,203 | Jun 30, 2026 |
| Jun 29, 2026 | Andrew Brannan EVP, Worldwide Sales | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -6,464 | $0.00 | $0 | 138 | Jun 30, 2026 |
| Jun 22, 2026 | Jeffrey W Baumgartner EVP, R&D | SOpen-market sale Common Stock10b5-1 | -1,170 | $168.23 | $197k | 16,405 | Jun 24, 2026 |
| Jun 2, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Common Stock10b5-1 | +3,907 | $41.49 | $162k | 21,482 | Jun 4, 2026 |
| Jun 3, 2026 | Scott Thomas EVP, General Counsel | MOption exercise Common Stock10b5-1 | +1,300 | $78.00 | $101k | 32,348 | Jun 4, 2026 |
| Jun 2, 2026 | Jeffrey W Baumgartner EVP, R&D | SOpen-market sale Common Stock10b5-1 | -3,907 | $168.54 | $658k | 17,575 | Jun 4, 2026 |
| Jun 3, 2026 | Scott Thomas EVP, General Counsel | SOpen-market sale Common Stock10b5-1 | -1,300 | $180.04 | $234k | 31,048 | Jun 4, 2026 |
| Jun 2, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Incentive Stock Option (right to buy)derivative10b5-1 | -804 | $0.00 | $0 | 0 | Jun 4, 2026 |
| Jun 3, 2026 | Scott Thomas EVP, General Counsel | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,300 | $0.00 | $0 | 4,642 | Jun 4, 2026 |
| Jun 2, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -3,103 | $0.00 | $0 | 0 | Jun 4, 2026 |
| May 29, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Common Stock10b5-1 | +10,000 | $38.34 | $383k | 28,746 | Jun 2, 2026 |
| May 29, 2026 | Andrew Brannan EVP, Worldwide Sales | SOpen-market sale Common Stock10b5-1 | -1,645 | $175.75 | $289k | 7,203 | Jun 2, 2026 |
| May 29, 2026 | Jeffrey W Baumgartner EVP, R&D | SOpen-market sale Common Stock10b5-1 | -11,171 | $171.65 | $1.9M | 17,575 | Jun 2, 2026 |
| May 29, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Incentive Stock Option (right to buy)derivative10b5-1 | -2,609 | $0.00 | $0 | 0 | Jun 2, 2026 |
| May 29, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -7,391 | $0.00 | $0 | 0 | Jun 2, 2026 |
| May 21, 2026 | Carl Jackson Alberty EVP, MSP | MOption exercise Common Stock | +1,080 | $0.00 | $0 | 40,858 | May 26, 2026 |
| May 21, 2026 | Jeffrey W Baumgartner EVP, R&D | MOption exercise Common Stock | +1,080 | $0.00 | $0 | 19,165 | May 26, 2026 |
| May 21, 2026 | Andrew Brannan EVP, Worldwide Sales | MOption exercise Common Stock | +925 | $0.00 | $0 | 9,311 | May 26, 2026 |
| May 21, 2026 | Denise Grode EVP, CHRO | MOption exercise Common Stock | +925 | $0.00 | $0 | 10,261 | May 26, 2026 |
| May 21, 2026 | Justin E Dougherty EVP, Global Operations | MOption exercise Common Stock | +1,080 | $0.00 | $0 | 6,956 | May 26, 2026 |
| May 21, 2026 | John Forsyth CEO | MOption exercise Common Stock | +6,171 | $0.00 | $0 | 76,187 | May 26, 2026 |
| May 21, 2026 | Scott Thomas EVP, General Counsel | MOption exercise Common Stock | +1,080 | $0.00 | $0 | 31,473 | May 26, 2026 |
| May 21, 2026 | Carl Jackson Alberty EVP, MSP | FTax withholding Common Stock | -419 | $166.62 | $70k | 40,439 | May 26, 2026 |
| May 21, 2026 | Jeffrey W Baumgartner EVP, R&D | FTax withholding Common Stock | -419 | $166.62 | $70k | 18,746 | May 26, 2026 |
| May 21, 2026 | John Forsyth CEO | FTax withholding Common Stock | -2,429 | $166.62 | $405k | 73,758 | May 26, 2026 |
50 of 359 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Carl Jackson AlbertyVP, MSP
- Jeffrey W BaumgartnerVP, R&D
- Andrew BrannanVP, Worldwide Sales
- Alexander M Daverndirector
- Justin E DoughertySVP, Global Operations
- John ForsythCEO
- Denise GrodeChief Human Resources Officer
- Muhammad Raghib Hussainpresident, officer, director
- Loan T Le Duydirector
- Catherine P Legodirector
- William D Mosleyceo, officer, director
- Venkatesh NathamuniChief Financial Officer
- Scott ThomasSr VP, General Counsel
- David J. Tupmandirector
Questions about CRUS
Answered from the filings on this page, as of the latest one.
Are insiders buying CRUS?
As of Sep 23, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 3 open-market sells worth $438k by 1 insider at CIRRUS LOGIC, INC. in the last 90 days, net -$438k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade CRUS on the open market?
Jeffrey W Baumgartner (EVP, R&D) sold $139k of CRUS on Sep 21, 2026 and filed the Form 4 on Sep 23, 2026. InsiderTell scored 6 (weak), under a 10b5-1 plan.
How many insiders file Form 4 at CIRRUS LOGIC, INC.?
14 people have filed a Form 4 at CIRRUS LOGIC, INC., among them Carl Jackson Alberty (VP, MSP), Jeffrey W Baumgartner (VP, R&D), Andrew Brannan (VP, Worldwide Sales). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.